Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer: Primary Results of DESTINY-Lung02

被引：0

作者：

Janne, P. ^{[1
]}

Goto, Y. ^{[2
]}

Kubo, T. ^{[3
]}

Ninomiya, K. ^{[4
]}

Kim, S. -W. ^{[5
]}

Planchard, D. ^{[6
]}

Ahn, M. -J. ^{[7
]}

Smit, E. F. ^{[8
]}

de Langen, A. J. ^{[9
]}

Perol, M. ^{[10
]}

Pons-Tostivint, E. ^{[11
]}

Novello, S. ^{[12
]}

Hayashi, H. ^{[13
]}

Shimizu, J. ^{[14
]}

Kim, D. -W. ^{[15
]}

Pereira, K. ^{[16
]}

Cheng, F. -C. ^{[16
]}

Taguchi, A. ^{[16
]}

Cheng, Y. ^{[16
]}

Goto, K. ^{[17
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA 02115 USA

[2] Natl Canc Ctr, Tokyo, Japan

[3] Okayama Univ Hosp, Ctr Clin Oncol, Okayama, Japan

[4] Okayama Univ Hosp, Okayama, Japan

[5] Asan Med Ctr, Seoul, South Korea

[6] Gustave Roussy, Villejuif, France

[7] Samsung Med Ctr, Seoul, South Korea

[8] Leiden Univ, Med Ctr, Leiden, Netherlands

[9] Netherlands Canc Inst, Amsterdam, Netherlands

[10] Leon Berard Ctr, Lyon, France

[11] Univ Nantes, Ctr Hosp Univ Nantes, Nantes, France

[12] Univ Turin, Dept Oncol, Azienda Osped Univ San Luigi Gonzaga, Orbassano, Italy

[13] Kindai Univ Hosp, Osaka, Japan

[14] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[15] Seoul Natl Univ Hosp, Seoul, South Korea

[16] Daiichi Sankyo Inc, Basking Ridge, NJ USA

[17] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

NSCLC; trastuzumab deruxtecan; HER2;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA13.10

引用

页码：S148 / S148

页数：1